Rare diseases
Investigational molecules
Locations
Margit Korut 50-52 Fszt. 9, Kerulet, 1027 Budapest, Hungary
Revita Kft. in Budapest, Hungary specialises in clinical trials of conditions such as Psoriatic arthropathy, Rheumatoid arthritis, Sjogren's syndrome, Axial spondyloarthritis, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in psoriatic arthritis, focusing on innovative treatments that enhance patient outcomes. The center's studies aim to improve the efficacy and safety of new therapeutic agents.
These studies contribute significantly to understanding the comparative effectiveness of novel biologics in managing psoriatic arthritis, offering insights into personalized treatment approaches.
Our institution is renowned for its comprehensive research in rheumatoid arthritis, exploring a wide array of therapeutic strategies to manage this chronic condition effectively.
Through these studies, the center is advancing the understanding of rheumatoid arthritis treatment, focusing on both efficacy and safety to improve patient quality of life.
The center is actively engaged in research on knee osteoarthritis, aiming to develop effective pain management strategies and improve functional outcomes for patients.
By investigating new therapeutic options, the center is contributing to the development of more effective treatments for knee osteoarthritis, addressing a significant need in musculoskeletal health.
Research at the center includes studies on polymyalgia rheumatica, focusing on the long-term safety and tolerability of emerging treatments.
These efforts are crucial in enhancing the understanding of treatment safety profiles, ultimately improving therapeutic strategies for polymyalgia rheumatica.
The center is pioneering research in autoimmune diseases, with a focus on pharmacokinetic studies to optimize treatment delivery and efficacy.
By exploring the pharmacokinetics of novel therapies, the center is enhancing the precision of treatment regimens for conditions like systemic lupus erythematosus and Sjögren’s disease.
Clinical trials currently enrolling participants at this site.
Study on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis
HungaryA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
HungaryStudy comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
HungaryStudy on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis
HungaryStudy of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis
HungaryA Study Testing Imeroprubart for Adults with Primary Sjogren's Disease with Moderate to Severe Symptoms
HungaryStudy on the Effects of IMVT-1402 for Adults with Difficult-to-Treat Rheumatoid Arthritis
HungaryStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments
HungaryStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Not Used Biologic Treatments
HungaryStudy of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment
HungaryStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
HungaryStudy on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis
HungaryGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
